AU2005275173A1 - Modified tissue marking pigment and method for modifying tissue marking pigment - Google Patents
Modified tissue marking pigment and method for modifying tissue marking pigment Download PDFInfo
- Publication number
- AU2005275173A1 AU2005275173A1 AU2005275173A AU2005275173A AU2005275173A1 AU 2005275173 A1 AU2005275173 A1 AU 2005275173A1 AU 2005275173 A AU2005275173 A AU 2005275173A AU 2005275173 A AU2005275173 A AU 2005275173A AU 2005275173 A1 AU2005275173 A1 AU 2005275173A1
- Authority
- AU
- Australia
- Prior art keywords
- particle
- pigment
- compound
- pigment according
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000049 pigment Substances 0.000 title claims description 95
- 238000000034 method Methods 0.000 title claims description 39
- 239000002245 particle Substances 0.000 claims description 118
- 210000001519 tissue Anatomy 0.000 claims description 93
- 150000001875 compounds Chemical class 0.000 claims description 29
- 239000002158 endotoxin Substances 0.000 claims description 27
- 229920001223 polyethylene glycol Polymers 0.000 claims description 22
- 229920006008 lipopolysaccharide Polymers 0.000 claims description 21
- 239000002202 Polyethylene glycol Substances 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 16
- 102000004169 proteins and genes Human genes 0.000 claims description 16
- 108090000623 proteins and genes Proteins 0.000 claims description 16
- 238000001179 sorption measurement Methods 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 11
- 210000000987 immune system Anatomy 0.000 claims description 10
- 239000011148 porous material Substances 0.000 claims description 10
- 102000004127 Cytokines Human genes 0.000 claims description 9
- 108090000695 Cytokines Proteins 0.000 claims description 9
- 238000007373 indentation Methods 0.000 claims description 9
- 229920000642 polymer Polymers 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 7
- 102000005962 receptors Human genes 0.000 claims description 7
- 108020003175 receptors Proteins 0.000 claims description 7
- 229920003169 water-soluble polymer Polymers 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 102000006495 integrins Human genes 0.000 claims description 6
- 108010044426 integrins Proteins 0.000 claims description 6
- 150000002617 leukotrienes Chemical class 0.000 claims description 6
- 241000588724 Escherichia coli Species 0.000 claims description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 4
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 claims description 4
- 229920002732 Polyanhydride Polymers 0.000 claims description 3
- 241000605862 Porphyromonas gingivalis Species 0.000 claims description 3
- VNYSSYRCGWBHLG-AMOLWHMGSA-N leukotriene B4 Chemical group CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-AMOLWHMGSA-N 0.000 claims description 3
- 210000003463 organelle Anatomy 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 1
- 206010018691 Granuloma Diseases 0.000 description 7
- 210000002540 macrophage Anatomy 0.000 description 7
- 230000008105 immune reaction Effects 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- -1 Poly(Ethylene Glycol) Polymers 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000028993 immune response Effects 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 108050003114 Coronin 1A Proteins 0.000 description 2
- 102100028233 Coronin-1A Human genes 0.000 description 2
- 101000946889 Homo sapiens Monocyte differentiation antigen CD14 Proteins 0.000 description 2
- 102100035877 Monocyte differentiation antigen CD14 Human genes 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000004905 finger nail Anatomy 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000000899 immune system response Effects 0.000 description 2
- 229960001438 immunostimulant agent Drugs 0.000 description 2
- 239000003022 immunostimulating agent Substances 0.000 description 2
- 230000003308 immunostimulating effect Effects 0.000 description 2
- 210000004324 lymphatic system Anatomy 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 210000001539 phagocyte Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000037390 scarring Effects 0.000 description 2
- 230000009919 sequestration Effects 0.000 description 2
- 210000004906 toe nail Anatomy 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010070245 Foreign body Diseases 0.000 description 1
- 208000005422 Foreign-Body reaction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000502522 Luscinia megarhynchos Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011902 gastrointestinal surgery Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 210000000680 phagosome Anatomy 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000032954 positive regulation of cell adhesion Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000018 receptor agonist Substances 0.000 description 1
- 229940044601 receptor agonist Drugs 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 239000002094 self assembled monolayer Substances 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/025—Semi-permanent tattoos, stencils, e.g. "permanent make-up"
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
- A61B2090/3937—Visible markers
- A61B2090/395—Visible markers with marking agent for marking skin or other tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/57—Compounds covalently linked to a(n inert) carrier molecule, e.g. conjugates, pro-fragrances
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Pigments, Carbon Blacks, Or Wood Stains (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Coloring (AREA)
- Inks, Pencil-Leads, Or Crayons (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58786404P | 2004-07-15 | 2004-07-15 | |
| US60/587,864 | 2004-07-15 | ||
| PCT/US2005/024865 WO2006019823A2 (en) | 2004-07-15 | 2005-07-14 | Modified tissue marking pigment and method for modifying tissue marking pigment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2005275173A1 true AU2005275173A1 (en) | 2006-02-23 |
Family
ID=35907879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2005275173A Abandoned AU2005275173A1 (en) | 2004-07-15 | 2005-07-14 | Modified tissue marking pigment and method for modifying tissue marking pigment |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20080028990A1 (enExample) |
| EP (1) | EP1786331A2 (enExample) |
| JP (1) | JP2008506701A (enExample) |
| AU (1) | AU2005275173A1 (enExample) |
| BR (1) | BRPI0513279A (enExample) |
| RU (1) | RU2007105589A (enExample) |
| WO (1) | WO2006019823A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007115291A2 (en) * | 2006-04-04 | 2007-10-11 | Freedom-2, Inc. | Tissue markings with discrete absorption particles |
| US20110009847A1 (en) | 2009-03-02 | 2011-01-13 | Seventh Sense Biosystems, Inc. | Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin |
| US20120277629A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Systems and methods for collection and/or manipulation of blood spots or other bodily fluids |
| US9033898B2 (en) | 2010-06-23 | 2015-05-19 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
| WO2012018486A2 (en) | 2010-07-26 | 2012-02-09 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
| WO2011094573A1 (en) | 2010-01-28 | 2011-08-04 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
| CN103068308B (zh) | 2010-07-16 | 2016-03-16 | 第七感生物系统有限公司 | 用于流体传输装置的低压环境 |
| WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
| US8808202B2 (en) | 2010-11-09 | 2014-08-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
| US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
| KR102013466B1 (ko) | 2011-04-29 | 2019-08-22 | 세븐쓰 센스 바이오시스템즈, 인크. | 유체들의 전달 및/또는 수용 |
| WO2012149155A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
| US20140379090A1 (en) * | 2011-08-08 | 2014-12-25 | Ecole Polytechnique Federale De Lausanne (Epfl) | In-vivo condition monitoring of metallic implants by electrochemical techniques |
| WO2022212691A1 (en) * | 2021-03-31 | 2022-10-06 | The Regents Of The University Of Colorado, A Body Corporate | Multistable photochromic pigments for intradermal use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4159659A (en) * | 1978-05-16 | 1979-07-03 | Carol Nightingale | Electrical marking device |
| US4973468A (en) * | 1989-03-22 | 1990-11-27 | Cygnus Research Corporation | Skin permeation enhancer compositions |
| US5115805A (en) * | 1990-02-23 | 1992-05-26 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
| US5543158A (en) * | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| US5472449A (en) * | 1993-07-26 | 1995-12-05 | Chou; Kuei C. | Permanent pigment applicator having a detachable needle coupler |
| US5445611A (en) * | 1993-12-08 | 1995-08-29 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal delivery with ultrasound and chemical enhancers |
| US5814599A (en) * | 1995-08-04 | 1998-09-29 | Massachusetts Insitiute Of Technology | Transdermal delivery of encapsulated drugs |
| US6013122A (en) * | 1998-08-18 | 2000-01-11 | Option Technologies, Inc. | Tattoo inks |
| CA2356705A1 (en) * | 1998-11-20 | 2000-06-02 | The General Hospital Corporation | Permanent, removable tissue markings |
| US6254852B1 (en) * | 1999-07-16 | 2001-07-03 | Dupont Pharmaceuticals Company | Porous inorganic targeted ultrasound contrast agents |
-
2005
- 2005-07-14 RU RU2007105589/04A patent/RU2007105589A/ru not_active Application Discontinuation
- 2005-07-14 US US11/571,962 patent/US20080028990A1/en not_active Abandoned
- 2005-07-14 EP EP05770972A patent/EP1786331A2/en not_active Withdrawn
- 2005-07-14 AU AU2005275173A patent/AU2005275173A1/en not_active Abandoned
- 2005-07-14 BR BRPI0513279-7A patent/BRPI0513279A/pt not_active IP Right Cessation
- 2005-07-14 JP JP2007521613A patent/JP2008506701A/ja active Pending
- 2005-07-14 WO PCT/US2005/024865 patent/WO2006019823A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| RU2007105589A (ru) | 2008-08-20 |
| WO2006019823A2 (en) | 2006-02-23 |
| BRPI0513279A (pt) | 2008-05-06 |
| JP2008506701A (ja) | 2008-03-06 |
| US20080028990A1 (en) | 2008-02-07 |
| EP1786331A2 (en) | 2007-05-23 |
| WO2006019823A3 (en) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2851234T3 (es) | Dispositivos de suministro y métodos para aumento cutáneo | |
| US20080028990A1 (en) | Modified Tissue Marking Pigment And Method For Modifying Tissue Marking Pigment | |
| CA2158638C (en) | A composition and a method for tissue augmentation | |
| US12161831B2 (en) | Microneedles and compositions for skin augmentation | |
| US20110087152A1 (en) | Fluidic tissue augmentation compositions and methods | |
| JP6618898B2 (ja) | 組織再生のための組織スキャフォールド材料および作製方法 | |
| EP2450079B1 (en) | Needle-like material | |
| JP2021509344A (ja) | 皮膚増強のための高装填マイクロニードル及び組成物 | |
| Mishra | Concise encyclopedia of biomedical polymers and polymeric biomaterials | |
| Bigham et al. | Microneedle patches: a new vantage point for diabetic wound treatments | |
| EP4190315A1 (en) | Exosomes-loaded biomimetic tissue-adhesive hydrogel patch | |
| TW201247179A (en) | Polyelectrolyte complex gels and soft tissue augmentation implants comprising the same | |
| WO2017177184A1 (en) | Removable tattoo ink and method of producing same | |
| KR102334072B1 (ko) | 경피 전달용 색소 마이크로구조체 | |
| Yellepeddi et al. | Nanotechnology-based applications for transdermal delivery of therapeutics | |
| CN119700713B (zh) | 一种双层嵌套结构微针及其应用 | |
| GB2639767A (en) | Microneedle devices for delivery of agents into the skin | |
| HK40009142A (en) | Delivery devices and methods for skin augmentation | |
| HK1210728B (zh) | 用於皮肤改善的递送装置和方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC1 | Assignment before grant (sect. 113) |
Owner name: FREEDOM-2, INC. Free format text: FORMER APPLICANT(S): FREEDOM-2, LLC |
|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |